Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00002663
Status:
COMPLETED
Last Update Posted:
2023-02-13
First Post:
1999-11-01
Brief Title:
Biological Therapy in Treating Patients at High-Risk or With Lymphoma Lymphoproliferative Disease or Malignancies
Sponsor:
Atara Biotherapeutics
Organization:
Atara Biotherapeutics
Organization Data
Organization:
Atara Biotherapeutics
Class:
INDUSTRY
Study ID:
95-024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Atara Biotherapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| Memorial Sloan Kettering Cancer Center | OTHER |